Specifically, 67% of the patients carrying pathogenic variants in USH2A presented syndromic RP with hearing impairment (Usher syndrome type II) whereas 33% had isolated RP, frequently mild forms with benign prognosis such as the pericentral RP subgroup29 (Supplementary Figure S1). Here, USH2A is linked to hearing loss disorder.